Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009.

Journal:

Journal of Clinical Oncology

Published:

2025-11-11

DOI:

10.1200/jco-25-01357

Affiliations:

18

Authors:

24

Go to article

Institutions	Authors	Share
San Gerardo Hospital, Italy	5.000000	0.21
University Medical Center Schleswig-Holstein (UKSH), Germany	4.000000	0.17
Hannover Medical School (MHH), Germany	2.000000	0.08
University Children's Hospital of Zurich, Switzerland	2.000000	0.08
St. Anna Children's Hospital, Austria	2.000000	0.08
Children's Hospital at Westmead (CHW), USYD, Australia	1.000000	0.04
University of Padova (UNIPD), Italy	1.000000	0.04
Schneider Children's Medical Center of Isreal, Israel	1.000000	0.04
Tel Aviv University (TAU), Israel	1.000000	0.04
University Medical Center Freiburg, Germany	1.000000	0.04
University Hospital in Motol, Czech Republic	1.000000	0.04
University of Würzburg (JMU), Germany	1.000000	0.04
Sydney Children's Hospital, Randwick, Australia	0.500000	0.02
University of New South Wales (UNSW Sydney), Australia	0.500000	0.02
Catholic University of the Sacred Heart (UCSC), Italy	0.500000	0.02
IRCCS Bambino Gesù Children's Hospital, Italy	0.500000	0.02

Interested in Oncology and Carcinogenesis?